| Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | Affiliation / Organization |
|---|---|---|---|---|
| 09:00-09:20 | 09:00-09:20 |
Is Diabetes a Cardiovascular Disease? |
José Luis Leiva Pons | Hospital Central Dr. Morones Prieto |
| 09:20-09:40 | 09:20-09:40 |
State-of-the-Art: New Antidiabetic Agents for the Treatment of Cardiovascular Disease |
Lingling Xu | Peking Union Medical College Hospital |
| 09:40-10:00 | 09:40-10:00 |
CardioDiabetology 2020: Focus on GLP1-RA. Design that Matters |
Enrique C. Morales Villegas | Cardiometabolic Research Center |
| 10:00-10:20 | 10:00-10:20 |
Treatment and Revascularization in Diabetic Patients with Acute Coronary Syndromes |
Yong Zeng | Beijing An Zhen Hospital, Capital Medical University |
| 10:20-10:30 | 10:20-10:30 |
Discussion |
||
| Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | Affiliation / Organization |
|---|---|---|---|---|
| 11:00-11:20 | 11:00-11:20 |
Role of ECG to Localize an Arrhythmogenic Substrate in Ventricular Tachycardias |
Ali Oto | Memorial Hospital |
| 11:20-11:40 | 11:20-11:40 |
VT Ablation in Structural Heart Diseases: A Case Based Discussion |
Fırat Özcan | Yuksek Ihtisas Heart and Vessel Hospital Department of Cardiac Electrophysiology Ankara City Hospital |
| 11:40-12:00 | 11:40-12:00 |
How to Optimize Epicardial Ablation in Ventricular Tachycardias? |
Chenxi Jiang | Beijing Anzhen Hosptial |
| 12:00-12:20 | 12:00-12:20 |
Solutions for Refractory Electrical Storm |
Xingpeng Liu | Beijing Chao-Yang Hospital |
| 12:20-12:30 | 12:20-12:30 |
Discussion |
||
| Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | Affiliation / Organization |
|---|---|---|---|---|
| 14:00-14:20 | 14:00-14:20 |
Novel Pharmacomechanical Treatment Options in VTE |
Oztekin Oto | Heart and Health Foundation of Turkey |
| 14:20-14:40 | 14:20-14:40 |
Iliofemoral Venous Reconstruction Techniques in VTE: Balloon Angioplasty and Stenting |
Orçun Gürbüz | Balikesir University, School of Medicine |
| 14:40-15:00 | 14:40-15:00 |
Medical Treatment in VTE |
Lihong Wang | Zhejiang Provincial people's hospital |
| 15:00-15:20 | 15:00-15:20 |
DVT in COVID-19: Does Standard Treatment Protocols Meet Our Needs? |
Xijie Zhu | |
| 15:20-15:30 | 15:20-15:30 |
Discussion |
||
| Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | Affiliation / Organization |
|---|---|---|---|---|
| 16:00-16:20 | 16:00-16:20 |
The Year in Coronary Interventions |
Davide Capodanno | University of Catania |
| 16:20-16:40 | 16:20-16:40 |
Characteristics and Significance of Healed Plaques in Patients with Acute Coronary Syndrome and Stable Angina: An in Vivo OCT and IVUS Study |
Chao Wang | The 2nd Affiliated Hospital of Harbin Medical University |
| 16:40-17:00 | 16:40-17:00 |
The Year in Interventions for Aortic Stenosis |
Darren Mylotte | Galway University Hospitals, Galway, Ireland |
| 17:00-17:20 | 17:00-17:20 |
Results of Left Ventricular Reconstruction With and Without Mitral Valve Surgery |
Yida Tang | Peking University Third Hospital |
| 17:20-17:30 | 17:20-17:30 |
Discussion |
||
| Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | Affiliation / Organization |
|---|---|---|---|---|
| 19:00-19:20 | 19:00-19:20 |
The Contribution of Inflammation to Residual Cardiovascular Risk |
Peter Libby | Brigham and Women's Hospital, Harvard Medical School |
| 19:20-19:40 | 19:20-19:40 |
Residual Risk from the Perspective of Epidemiology |
Dong Zhao | Beijing Anzhen Hospital |
| 19:40-20:00 | 19:40-20:00 |
Triglyceride-Rich Lipoproteins Residual Risk |
Raul Santos | University of Sao Paulo |
| 20:00-20:20 | 20:00-20:20 |
Role of Gut Microbiota and Ceramide in the Cardiometabolic Diseases |
Changtao Jiang | Peking University |
| 20:20-20:40 | 20:20-20:40 |
Lp(a) Residual Risk |
Samia Mora | Brigham and Women's Hospital, Harvard Medical School |
| 20:40-21:00 | 20:40-21:00 |
Residual Risk Associated with Obesity and Insulin-Resistance |
Yida Tang | Peking University Third Hospital |
| 21:00-21:10 | 21:00-21:10 |
Discussion |
||